Mitogen-activated protein kinase inhibitors reduce the nuclear accumulation of phosphorylated Smads by inhibiting Imp 7 or Imp 8 in HepG2 cells

Hu,Xiangpeng; Kan,Hongwei; Boye,Alex; Jiang,Yufeng; Wu,Chao; Yang,Yan

doi:10.3892/ol.2018.7926

Mitogen-activated protein kinase inhibitors reduce the nuclear accumulation of phosphorylated Smads by inhibiting Imp 7 or Imp 8 in HepG2 cells

Authors:
- Xiangpeng Hu
- Hongwei Kan
- Alex Boye
- Yufeng Jiang
- Chao Wu
- Yan Yang
View Affiliations

Affiliations: Department of Pharmacology, Institute of Natural Medicine, Anhui Medical University, Hefei, Anhui 230032, P.R. China
Published online on: February 2, 2018 https://doi.org/10.3892/ol.2018.7926
Pages: 4867-4872
Copyright: © Hu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The transforming growth factor (TGF)-β/Smad signaling pathway is involved in hepatocellular carcinoma development. Smad2 and Smad3 are phosphorylated following TGF‑β1 stimulation and subsequently oligomerize with Smad4 to form the Smad2/3/4 complex, which translocates into the nucleus and regulates target genes, including plasminogen activator inhibitor type 1 (PAI1). Importin (Imp)7 and Imp8 are responsible for transporting phosphorylated (p)Smad2/3 and Smad4 into the nucleus. In our previous study, it was demonstrated that mitogen‑activated protein kinase (MAPK) inhibitors, including inhibitors of extracellular signal‑regulated kinase (ERK), c‑Jun N‑terminal kinase (JNK) and p38 could inhibit the transcription of PAI1, but ERK inhibitor had no significant effect on the phosphorylation of Smad2/3, and the formation of Smad2/3/4 complexes, which was different from the effect of JNK or p38 inhibitor. We hypothesized that MAPK inhibitors, particularly ERK inhibitor, reduced the transport of Smads into the nucleus by affecting Imp7 and Imp8. To confirm this hypothesis, HepG2 cells were incubated with different MAPK inhibitors for 5 h and subsequently stimulated with TGF‑β1 for 1 h. Next, the intracellular locations of Smads (pSmad2C, pSmad2L, pSmad3C, pSmad3L and Smad4) and Imp7/8 were detected using immunofluorescence staining assays, and the expression of Imp7/8 was investigated using immunoblotting. It was revealed that JNK or p38 inhibitor decreased the phosphorylation of Smad2C, Smad2L and Smad3L, and affected their nuclear accumulation. Although only inhibiting the phosphorylation of Smad2C, ERK inhibitor affected the nuclear accumulation of pSmad2C, pSmad2L, pSmad3C and pSmad3L. The three MAPK inhibitors attenuated the nuclear distribution of Smad4, and the expression and nuclear accumulation of Imp7. ERK and JNK inhibitors attenuated the expression and nuclear accumulation of Imp8. Thus, the results of the present study suggest that MAPK inhibitors, particularly ERK inhibitor, modulate the nuclear accumulation of Smads via the inhibition of Imp 7/8.

View Figures

View References

1	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar
2	Heldin CH and Moustakas A: Role of Smads in TGFβ signaling. Cell Tissue Res. 347:21–36. 2012. View Article : Google Scholar : PubMed/NCBI
3	Kretzschmar M, Doody J, Timokhina I and Massagué J: A mechanism of repression of TGFbeta/Smad signaling by oncogenic Ras. Genes Dev. 13:804–816. 1999. View Article : Google Scholar : PubMed/NCBI
4	Tahashi Y, Matsuzaki K, Date M, Yoshida K, Furukawa F, Sugano Y, Matsushita M, Himeno Y, Inagaki Y and Inoue K: Differential regulation of TGF-beta signal in hepatic stellate cells between acute and chronic rat liver injury. Hepatology. 35:49–61. 2002. View Article : Google Scholar : PubMed/NCBI
5	Derynck R and Zhang YE: Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 425:577–584. 2003. View Article : Google Scholar : PubMed/NCBI
6	Matsuzaki K, Murata M, Yoshida K, Sekimoto G, Uemura Y, Sakaida N, Kaibori M, Kamiyama Y, Nishizawa M, Fujisawa J, et al: Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma. Hepatology. 46:48–57. 2007. View Article : Google Scholar : PubMed/NCBI
7	Freytag J, Wilkins-Port CE, Higgins CE, Higgins SP, Samarakoon R and Higgins PJ: PAI-1 mediates the TGF-beta1+EGF-induced ‘scatter’ response in transformed human keratinocytes. J Invest Dermatol. 130:2179–2190. 2010. View Article : Google Scholar : PubMed/NCBI
8	Wrighton KH, Willis D, Long J, Liu F, Lin X and Feng XH: Small C-terminal domain phosphatases dephosphorylate the regulatory linker regions of Smad2 and Smad3 to enhance transforming growth factor-beta signaling. J Biol Chem. 281:38365–38375. 2006. View Article : Google Scholar : PubMed/NCBI
9	Javelaud D and Mauviel A: Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: Implications for carcinogenesis. Oncogene. 24:5742–5750. 2005. View Article : Google Scholar : PubMed/NCBI
10	Janda E, Lehmann K, Killisch I, Jechlinger M, Herzig M, Downward J, Beug H and Grünert S: Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: Dissection of Ras signaling pathways. J Cell Biol. 156:299–313. 2002. View Article : Google Scholar : PubMed/NCBI
11	Kfir S, Ehrlich M, Goldshmid A, Liu X, Kloog Y and Henis YI: Pathway- and expression level-dependent effects of oncogenic N-Ras: p27(Kip1) mislocalization by the Ral-GEF pathway and Erk-mediated interference with Smad signaling. Mol Cell Biol. 25:8239–8250. 2005. View Article : Google Scholar : PubMed/NCBI
12	Iwayama H, Sakamoto T, Nawa A and Ueda N: Crosstalk between smad and mitogen-activated protein kinases for the regulation of apoptosis in cyclosporine a-induced renal tubular injury. Nephron Extra. 1:178–189. 2011. View Article : Google Scholar : PubMed/NCBI
13	Liu Q, Zhang Y, Mao H, Chen W, Luo N, Zhou Q, Chen W and Yu X: A crosstalk between the Smad and JNK signaling in the TGF-β-induced epithelial-mesenchymal transition in rat peritoneal mesothelial cells. PLoS One. 7:e320092012. View Article : Google Scholar : PubMed/NCBI
14	Wang FM, Hu T and Zhou X: p38 mitogen-activated protein kinase and alkaline phosphatase in human dental pulp cells. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 102:114–118. 2006. View Article : Google Scholar : PubMed/NCBI
15	Furukawa F, Matsuzaki K, Mori S, Tahashi Y, Yoshida K, Sugano Y, Yamagata H, Matsushita M, Seki T, Inagaki Y, et al: p38 MAPK mediates fibrogenic signal through Smad3 phosphorylation in rat myofibroblasts. Hepatology. 38:879–889. 2003. View Article : Google Scholar : PubMed/NCBI
16	Abécassis L, Rogier E, Vazquez A, Atfi A and Bourgeade MF: Evidence for a role of MSK1 in transforming growth factor-beta-mediated responses through p38alpha and Smad signaling pathways. J Biol Chem. 279:30474–30479. 2004. View Article : Google Scholar : PubMed/NCBI
17	He S, Liu X, Yang Y, Huang W, Xu S, Yang S, Zhang X and Roberts MS: Mechanisms of transforming growth factor beta(1)/Smad signalling mediated by mitogen-activated protein kinase pathways in keloid fibroblasts. Br J Dermatol. 162:538–546. 2010. View Article : Google Scholar : PubMed/NCBI
18	Boye A, Kan H, Wu C, Jiang Y, Yang X, He S and Yang Y: MAPK inhibitors differently modulate TGF-β/Smad signaling in HepG2 cells. Tumour Biol. 36:3643–3651. 2015. View Article : Google Scholar : PubMed/NCBI
19	Hill CS: Nucleocytoplasmic shuttling of Smad proteins. Cell Res. 19:36–46. 2009. View Article : Google Scholar : PubMed/NCBI
20	Xu L, Yao X, Chen X, Lu P, Zhang B and Ip YT: Msk is required for nuclear import of TGF-{beta}/BMP-activated Smads. J Cell Biol. 178:981–994. 2007. View Article : Google Scholar : PubMed/NCBI
21	Yao X, Chen X, Cottonham C and Xu L: Preferential utilization of Imp7/8 in nuclear import of Smads. J Biol Chem. 283:22867–22874. 2008. View Article : Google Scholar : PubMed/NCBI
22	Matsuzaki K: Smad phospho-isoforms direct context-dependent TGF-β signaling. Cytokine Growth Factor Rev. 24:385–399. 2013. View Article : Google Scholar : PubMed/NCBI
23	Murata M, Matsuzaki K, Yoshida K, Sekimoto G, Tahashi Y, Mori S, Uemura Y, Sakaida N, Fujisawa J, Seki T, et al: Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B. Hepatology. 49:1203–1217. 2009. View Article : Google Scholar : PubMed/NCBI
24	Nagata H, Hatano E, Tada M, Murata M, Kitamura K, Asechi H, Narita M, Yanagida A, Tamaki N, Yagi S, et al: Inhibition of c-Jun NH2-terminal kinase switches Smad3 signaling from oncogenesis to tumor-suppression in rat hepatocellular carcinoma. Hepatology. 49:1944–1953. 2009. View Article : Google Scholar : PubMed/NCBI
25	Kawamata S, Matsuzaki K, Murata M, Seki T, Matsuoka K, Iwao Y, Hibi T and Okazaki K: Oncogenic Smad3 signaling induced by chronic inflammation is an early event in ulcerative colitis-associated carcinogenesis. Inflamm Bowel Dis. 17:683–695. 2011. View Article : Google Scholar : PubMed/NCBI
26	Velden JL, Alcorn JF, Guala AS, Badura EC and Janssen-Heininger YM: c-Jun N-terminal kinase 1 promotes transforming growth factor-β1-induced epithelial-to-mesenchymal transition via control of linker phosphorylation and transcriptional activity of Smad3. Am J Respir Cell Mol Biol. 44:571–581. 2011. View Article : Google Scholar : PubMed/NCBI
27	Sekimoto G, Matsuzaki K, Yoshida K, Mori S, Murata M, Seki T, Matsui H, Fujisawa J and Okazaki K: Reversible Smad-dependent signaling between tumor suppression and oncogenesis. Cancer Res. 67:5090–5096. 2007. View Article : Google Scholar : PubMed/NCBI
28	Hough C, Radu M and Doré JJ: Tgf-beta induced Erk phosphorylation of smad linker region regulates smad signaling. PLoS One. 7:e425132012. View Article : Google Scholar : PubMed/NCBI
29	Mori S, Matsuzaki K, Yoshida K, Furukawa F, Tahashi Y, Yamagata H, Sekimoto G, Seki T, Matsui H, Nishizawa M, et al: TGF-beta and HGF transmit the signals through JNK-dependent Smad2/3 phosphorylation at the linker regions. Oncogene. 23:7416–7429. 2004. View Article : Google Scholar : PubMed/NCBI
30	Matsuzaki K, Kitano C, Murata M, Sekimoto G, Yoshida K, Uemura Y, Seki T, Taketani S, Fujisawa J and Okazaki K: Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer. Cancer Res. 69:5321–5330. 2009. View Article : Google Scholar : PubMed/NCBI
31	De Bosscher K, Hill CS and Nicolás FJ: Molecular and functional consequences of Smad4 C-terminal missense mutations in colorectal tumour cells. Biochem J. 379:209–216. 2004. View Article : Google Scholar : PubMed/NCBI
32	Chen HB, Rud JG, Lin K and Xu L: Nuclear targeting of transforming growth factor-beta-activated Smad complexes. J Biol Chem. 280:21329–21336. 2005. View Article : Google Scholar : PubMed/NCBI
33	Reguly T and Wrana JL: In or out? The dynamics of Smad nucleocytoplasmic shuttling. Trends Cell Biol. 13:216–220. 2003. View Article : Google Scholar : PubMed/NCBI
34	Inman GJ, Nicolás FJ and Hill CS: Nucleocytoplasmic shuttling of Smads 2, 3 and 4 permits sensing of TGF-beta receptor activity. Mol Cell. 10:283–294. 2002. View Article : Google Scholar : PubMed/NCBI
35	Kurisaki A, Kose S, Yoneda Y, Heldin CH and Moustakas A: Transforming growth factor-beta induces nuclear import of Smad3 in an importin-beta1 and Ran-dependent manner. Mol Biol Cell. 12:1079–1091. 2001. View Article : Google Scholar : PubMed/NCBI
36	Schmierer B, Tournier AL, Bates PA and Hill CS: Mathematical modeling identifies Smad nucleocytoplasmic shuttling as a dynamic signal-interpreting system. Proc Natl Acad Sci USA. 105:pp. 6608–6613. 2008; View Article : Google Scholar : PubMed/NCBI
37	Zhang J, Ito H, Wate R, Ohnishi S, Nakano S and Kusaka H: Altered distributions of nucleocytoplasmic transport-related proteins in the spinal cord of a mouse model of amyotrophic lateral sclerosis. Acta Neuropathol. 112:673–680. 2006. View Article : Google Scholar : PubMed/NCBI